[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361358-105":59,"doc-detail-361358-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mechanism-of-lovastatin-in-promoting-ferroptosis-of-prostate-cancer-cells-by-regulating-the-mevalonate-pathway","Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway","","Prostate cancer is a frequent malignancy in men, and advanced-stage treatment options remain limited. Statins show antitumor activity in prostate cancer, yet the precise mechanisms are not fully resolved. This study tested clinically used statins in prostate cancer cells, identifying lovastatin as the strongest inhibitor of proliferation, migration, and invasion. Ferroptosis was assessed through Fe2+ and ROS, mitochondrial membrane potential, ferroptosis-related proteins, and mitochondrial morphology, with rescue by deferoxamine and mevalonate supplementation. Lovastatin effects were reversed by deferoxamine and MVA restored viability, oxidative stress, iron levels, MVA enzymes, and ferroptosis markers, supporting an MVA-ferroptosis therapeutic axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mechanism-of-lovastatin-in-promoting-ferroptosis-of-prostate-cancer-cells-by-regulating-the-mevalonate-pathway/361358/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mechanism-of-lovastatin-in-promoting-ferroptosis-of-prostate-cancer-cells-by-regulating-the-mevalonate-pathway/361358.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was lovastatin studied in prostate cancer cells?","Question",{"text":112,"@type":113},"Statins have antitumor activity in prostate cancer, but the underlying mechanism was unclear. The study aimed to test whether lovastatin suppresses prostate cancer by triggering ferroptosis through inhibition of the mevalonate (MVA) pathway.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did researchers determine whether lovastatin induces ferroptosis?",{"text":117,"@type":113},"They measured intracellular Fe2+ and reactive oxygen species (ROS), assessed mitochondrial membrane potential, evaluated ferroptosis-related protein expression, and examined ultrastructural mitochondrial changes. Deferoxamine was used as a ferroptosis inhibitor to rescue the effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What role do MVA supplementation and deferoxamine play in the conclusions?",{"text":121,"@type":113},"Deferoxamine reversed lovastatin-induced suppression of aggressiveness and ferroptosis markers, confirming ferroptosis involvement. Mevalonate supplementation restored cell viability, normalized iron and oxidative stress, and reversed changes in MVA pathway enzymes and ferroptosis-associated proteins.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361358,1790196759,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","European Journal of Histochemistry 2026; volume 70:4575  \nMechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway  \nYanhong Xiao,1,2* Zhengdao Liu,1* Yougang Feng,2 Han Zhu,1 Bo Wang,1 Shulian Chen,1 Guobiao Liang1  \n1Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi 2Department of Urology, Suining Central Hospital, Suining, China  \n*These authors contributed equally to this work.  \nABSTRACT  \nProstate cancer (PCa) is a common malignancy in men with limited therapeutic options at advanced stages. Statins, widely prescribed lipid-lowering agents, have demonstrated antitumor activity in PCa, but underlying mechanisms are not fully understood. Studies suggested that tumor progression is facilitated upon activation of mevalonate (MVA) pathway, while it is reduced via MVA pathway inhibition–induced ferroptosis. Therefore, this study aimed to determine whether lovastatin suppresses prostate cancer progression by inducing ferroptosis through inhibition of the MVA pathway. Five clinically used statins were screened in prostate cancer cell lines to identify the most effective compound. Cell proliferation, migration, and invasion were assessed. Ferroptosis was evaluated by measuring intracellular Fe2+ and reactive oxygen species (ROS) levels, mitochondrial membrane potential, ferroptosis-related protein expression, and ultrastructural mitochondrial alterations. Rescue experiments were performed using the ferroptosis inhibitor deferoxamine and MVA supplementation. Lovastatin exhibited the strongest inhibitory effect, significantly reducing proliferation, migration, and invasion. Lovastatin significantly suppressing PCa cell aggressiveness and inducing ferroptosis, as evidenced by typical biochemical and morphological markers, all of which were reversed by deferoxamine. MVA supplementation restored cell viability, normalized oxidative stress and iron levels, and reversed alterations in MVA pathway enzymes and ferroptosis-associated proteins. Lovastatin suppresses prostate cancer cell growth and invasiveness by inhibiting the MVA pathway and inducing ferroptosis, highlighting the MVA-ferroptosis axis as a potential therapeutic target for PCa.  \nKey words: prostate cancer; lovastatin; MVA pathway; ferroptosis.  \nCorrespondence: Prof. Guobiao Liang, Department of Urology, Affiliated Hospital of Zunyi Medical University,  \nNo.149 Dalian Road, Huichuan District, Zunyi, Guizhou Province, 563099, China. E-mail: [lgb11112021@163.com](lgb11112021@163.com)  \n[Prof. Shulian Chen](Prof. Shulian Chen), Department of Urology, Affiliated Hospital of Zunyi Medical University, No.149 Dalian Road,  \nHuichuan District, Zunyi, Guizhou Province, 563099, China. E-mail: [cslzmu@163.com](cslzmu@163.com)  \n[Conflict of interest:](Conflict of interest: the authors declare no competing interests and all authors confirm accuracy)[ the authors declare no competing interests and all authors confirm accuracy](Conflict of interest: the authors declare no competing interests and all authors confirm accuracy).  \nAvailability of data and materials: the datasets used and analysed during the current study are available from the corresponding author Guobiao Liang on reasonable request.  \nFunding: this work was supported by the Special Fund for Training outstanding Young Scientific and Technological Talents of Guizhou Province, Grant no. (2015)31 .  \n[European Journal of Histochemistry 2026; 70:4575]  \nIntroduction  \nProstate cancer (PCa) ranks as the fourth most diagnosed cancer worldwide and is the second most prevalent malignancy in men, with over 1.3 million new cases are diagnosed annually, with over 10 million men currently living with PCa. Its mortality rate continues to rise, posing a significant threat to male health and survival.1-3 Current therapeutic strategies for PCa include radical prostatectomy, radiotherapy, chemotherapy, bone-targeted therapy, poly (ADP-ribose) polymerase-1 (PA","cbCaiilllBufWqZR","https://ap.wps.com/l/cbCaiilllBufWqZR","pdf",475821,11,"English","# Abstract\n# Introduction","[{\"question\":\"Why was lovastatin studied in prostate cancer cells?\",\"answer\":\"Statins have antitumor activity in prostate cancer, but the underlying mechanism was unclear. The study aimed to test whether lovastatin suppresses prostate cancer by triggering ferroptosis through inhibition of the mevalonate (MVA) pathway.\"},{\"question\":\"How did researchers determine whether lovastatin induces ferroptosis?\",\"answer\":\"They measured intracellular Fe2+ and reactive oxygen species (ROS), assessed mitochondrial membrane potential, evaluated ferroptosis-related protein expression, and examined ultrastructural mitochondrial changes. Deferoxamine was used as a ferroptosis inhibitor to rescue the effects.\"},{\"question\":\"What role do MVA supplementation and deferoxamine play in the conclusions?\",\"answer\":\"Deferoxamine reversed lovastatin-induced suppression of aggressiveness and ferroptosis markers, confirming ferroptosis involvement. Mevalonate supplementation restored cell viability, normalized iron and oxidative stress, and reversed changes in MVA pathway enzymes and ferroptosis-associated proteins.\"}]","Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway | PDF",1790144043,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b59fe34e7a6748349ccdb10b930e36b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b31a324a7d976f7058acf429ddb3ef3c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c38748fa50d6c5b058d62e105dfee258.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/375fa64a3c673210259ff3c7adc2f34e.webp",980,1306]